Dong Chunli, Sun Yindi, Zhang Ying, Qin Bianni, Lei Tao
Department of Anesthesiology and Operation, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Pain Ward of Orthopedics Department of TCM, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.
J Oncol. 2022 Sep 16;2022:8177948. doi: 10.1155/2022/8177948. eCollection 2022.
Osteosarcoma (OS) is a rare form of malignant bone cancer that is usually detected in young adults and adolescents. This disease shows a poor prognosis owing to its metastatic status and resistance to chemotherapy. Hence, it is necessary to design a risk model that can successfully forecast the OS prognosis in patients.
The researchers retrieved the RNA sequencing data and follow-up clinical data related to OS patients from the TARGET and GEO databases, respectively. The coxph function in R software was used for carrying out the Univariate Cox regression analysis for deriving the aging-based genes related sto the OS prognosis. The researchers conducted consistency clustering using the ConcensusClusterPlus R package. The R software package ESTIMATE, MCPcounter, and GSVA packages were used for assessing the immune scores of various subtypes using the ssGSEA technique, respectively. The Univariate Cox and Lasso regression analyses were used for screening and developing a risk model. The ROC curves were constructed, using the pROC package. The performance of their developed risk model and designed survival curve was conducted, with the help of the Survminer package.
The OS patients were classified into 2 categories, as per the aging-related genes. The results revealed that the Cluster 1 patients showed a better prognosis than the Cluster 2 patients. Both clusters showed different immune microenvironments. Additional screening of the prognosis-associated genes revealed the presence of 5 genes, i.e., ERCC4, GPX4, EPS8, TERT, and STAT5A, and these data were used for developing the risk model. This risk model categorized the training set samples into the high- and low-risk groups. The patients classified into the high-risk group showed a poor OS prognosis compared to the low-risk patients. The researchers verified the reliability and robustness of the designed 5-gene signature using the internal and external datasets. This risk model was able to effectively predict the prognosis even in the samples having differing clinical features. Compared with other models, the 5- gene model performs better in predicting the risk of osteosarcoma.
The 5-gene signature developed by the researchers in this study could be effectively used for forecasting the OS prognosis in patients.
骨肉瘤(OS)是一种罕见的恶性骨癌,通常在年轻成年人和青少年中被发现。由于其转移状态和对化疗的耐药性,这种疾病的预后较差。因此,有必要设计一种能够成功预测骨肉瘤患者预后的风险模型。
研究人员分别从TARGET和GEO数据库中检索了与骨肉瘤患者相关的RNA测序数据和随访临床数据。使用R软件中的coxph函数进行单变量Cox回归分析,以得出与骨肉瘤预后相关的衰老相关基因。研究人员使用ConcensusClusterPlus R包进行一致性聚类。分别使用R软件包ESTIMATE、MCPcounter和GSVA包,通过单样本基因集富集分析(ssGSEA)技术评估各种亚型的免疫评分。使用单变量Cox和Lasso回归分析进行筛选并建立风险模型。使用pROC包构建ROC曲线。借助Survminer包对所建立的风险模型的性能和设计的生存曲线进行分析。
根据衰老相关基因,骨肉瘤患者被分为两类。结果显示,第1组患者的预后优于第2组患者。两组显示出不同的免疫微环境。对预后相关基因的进一步筛选发现了5个基因,即ERCC4、GPX4、EPS8、TERT和STAT5A,这些数据被用于建立风险模型。该风险模型将训练集样本分为高风险组和低风险组。与低风险患者相比,被分类为高风险组患者的骨肉瘤预后较差。研究人员使用内部和外部数据集验证了所设计的5基因特征的可靠性和稳健性。即使在具有不同临床特征的样本中,该风险模型也能够有效预测预后。与其他模型相比,5基因模型在预测骨肉瘤风险方面表现更好。
本研究中研究人员开发的5基因特征可有效用于预测骨肉瘤患者的预后。